[go: up one dir, main page]

ES549817A0 - Un metodo para producir proteina tensioactiva alveolar - Google Patents

Un metodo para producir proteina tensioactiva alveolar

Info

Publication number
ES549817A0
ES549817A0 ES549817A ES549817A ES549817A0 ES 549817 A0 ES549817 A0 ES 549817A0 ES 549817 A ES549817 A ES 549817A ES 549817 A ES549817 A ES 549817A ES 549817 A0 ES549817 A0 ES 549817A0
Authority
ES
Spain
Prior art keywords
surface protein
asp
proteins
alveolar surface
producing alveolar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549817A
Other languages
English (en)
Other versions
ES8801517A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scios LLC
Original Assignee
California Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Biotechnology Inc filed Critical California Biotechnology Inc
Publication of ES549817A0 publication Critical patent/ES549817A0/es
Publication of ES8801517A1 publication Critical patent/ES8801517A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/30—Signal or leader sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES549817A 1984-12-11 1985-12-11 Un metodo para producir proteina tensioactiva alveolar Expired ES8801517A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/680,358 US4659805A (en) 1984-12-11 1984-12-11 Recombinant alveolar surfactant protein

Publications (2)

Publication Number Publication Date
ES549817A0 true ES549817A0 (es) 1988-01-16
ES8801517A1 ES8801517A1 (es) 1988-01-16

Family

ID=24730771

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549817A Expired ES8801517A1 (es) 1984-12-11 1985-12-11 Un metodo para producir proteina tensioactiva alveolar

Country Status (14)

Country Link
US (1) US4659805A (es)
EP (1) EP0210189B1 (es)
JP (3) JPH07108917B2 (es)
KR (1) KR900004798B1 (es)
AT (1) ATE115147T1 (es)
AU (1) AU585579B2 (es)
DE (2) DE3590648T1 (es)
DK (1) DK172227B1 (es)
ES (1) ES8801517A1 (es)
GB (1) GB2181138B (es)
HK (1) HK1005883A1 (es)
IE (1) IE67067B1 (es)
NO (1) NO177678C (es)
WO (1) WO1986003408A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US4933280A (en) * 1984-12-11 1990-06-12 California Biotechnology Inc. Recombinant DNA sequence encoding Alveolar Surfactant Protein
US5430020A (en) * 1984-12-11 1995-07-04 Scios Nova Inc. Recombinant alveolar surfactant protein
US5840527A (en) * 1984-12-11 1998-11-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Recombinant alveolar surfactant protein
US5169761A (en) * 1984-12-11 1992-12-08 California Biotechnology Inc. Dna encoding and expression systems for alveolar surfactant proteins
MX169643B (es) * 1985-04-12 1993-07-16 Oronzio De Nora Impianti Electrodo para procesos electroquimicos, procedimiento para su produccion y cuba de electrolisis conteniendo dicho electrodo
US5055553A (en) * 1985-09-26 1991-10-08 Genetics Institute Inc. Low molecular weight pulmonary surfactant proteins
US4918161A (en) * 1985-09-26 1990-04-17 Genetics Institute, Inc. Low molecular weight pulmonary surfactant proteins
EP0240550A4 (en) * 1985-09-26 1989-09-19 Genetics Inst TENSIO-ACTIVE PULMONARY PROTEINS.
US4882422A (en) * 1985-10-24 1989-11-21 Genetics Institute, Inc. Pulmonary surfactant proteins
JPS63503222A (ja) * 1986-05-06 1988-11-24 サイオス　ノバ　インコーポレイテッド 肺の疎水性界面活性物質に結合した分子量６，０００ダルトンのタンパク質及びその多量体
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
WO1988003170A1 (en) * 1986-10-24 1988-05-05 Whitsett Jeffrey A Pulmonary hydrophobic surfactant-associated proteins
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト，ジエフリー　エイ． 肺胞疎水性界面活性物質関連タンパク質
WO1988005820A1 (en) * 1987-01-29 1988-08-11 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US5260273A (en) * 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US6613734B2 (en) 1988-01-06 2003-09-02 The Scripps Research Institute Peptides-containing liposomal surfactants
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
EP0458167B1 (en) * 1990-05-21 1997-04-23 Abbott Laboratories Fatty acid-pulmonary surfactant conjugates
GB9120005D0 (en) * 1991-09-19 1991-11-06 Wellcome Found Method of administering phospholipid dispersions
US5272252A (en) * 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
DK1173194T3 (da) * 1999-01-19 2004-10-18 Altana Pharma Ag Rekombinant SP-A til behandlingen eller forebyggelsen af lungeinfektion og -inflammation
EP1216052A1 (en) 1999-09-16 2002-06-26 Byk Gulden Lomberg Chemische Fabrik GmbH Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
JP2001137349A (ja) 1999-11-16 2001-05-22 Asahi Optical Co Ltd 内視鏡用噴霧具
AU2001278864A1 (en) * 2000-06-30 2002-01-30 University Of Cincinnati Peptides with antioxidant and antimicrobial properties
JP4559731B2 (ja) 2001-10-11 2010-10-13 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 肺サーファクタントの新規使用
SE0203591D0 (sv) 2002-12-04 2002-12-04 Siemens Elema Ab Förfarande för beredning av ett mediakament och en medicinsk anordning
EP1781323B1 (en) 2004-08-06 2010-02-17 Nycomed GmbH Composition comprising a pulmonary surfactant and a tnf-derived peptide
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
ES2380046T3 (es) 2005-01-06 2012-05-08 Discovery Laboratories, Inc. Régimen para el tratamiento con tensioactivos para tratar o prevenir la displasia broncopulmonar
MX2009003002A (es) 2006-09-19 2009-06-01 Discovery Lab Inc Formulaciones de tensioactivos pulmonares y metodos para promover la aclaracion del moco.
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
EP2370068A4 (en) 2008-12-10 2015-09-23 Paka Pulmonary Pharmaceuticals Inc METHOD AND COMPOSITIONS FOR DELIVERING MEDICAMENTS TO THE LUNG
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4506013A (en) * 1980-10-03 1985-03-19 Eli Lilly And Company Stabilizing and selecting recombinant DNA host cells
US4312860A (en) * 1980-10-24 1982-01-26 Regents Of The University Of California Lung surfactant compositions
US4562003A (en) * 1984-10-26 1985-12-31 California Biotechnology, Inc. Monoclonal antibodies against alveolar surfactant protein
EP0217822B1 (en) * 1985-02-13 1993-05-12 Scios Nova Inc. Human metallothionein-ii promoter in mammalian expression system

Also Published As

Publication number Publication date
IE853133L (en) 1986-06-11
NO863197D0 (no) 1986-08-07
ATE115147T1 (de) 1994-12-15
JPH0751066A (ja) 1995-02-28
GB8619801D0 (en) 1986-09-24
WO1986003408A1 (en) 1986-06-19
DK382786D0 (da) 1986-08-11
US4659805A (en) 1987-04-21
DK382786A (da) 1986-10-13
JP2500197B2 (ja) 1996-05-29
ES8801517A1 (es) 1988-01-16
DE3587958D1 (de) 1995-01-19
KR900004798B1 (ko) 1990-07-06
JPH07108917B2 (ja) 1995-11-22
JPH08224091A (ja) 1996-09-03
HK1005883A1 (en) 1999-01-29
DE3590648T1 (es) 1987-02-19
EP0210189B1 (en) 1994-12-07
GB2181138A (en) 1987-04-15
EP0210189A4 (en) 1988-11-09
IE67067B1 (en) 1996-02-21
NO177678B (no) 1995-07-24
JPS62501122A (ja) 1987-05-07
DE3587958T2 (de) 1995-05-04
NO177678C (no) 1995-11-01
EP0210189A1 (en) 1987-02-04
DK172227B1 (da) 1998-01-12
AU585579B2 (en) 1989-06-22
NO863197L (no) 1986-08-07
KR870700019A (ko) 1987-02-28
AU5308986A (en) 1986-07-01
GB2181138B (en) 1989-01-25

Similar Documents

Publication Publication Date Title
ES549817A0 (es) Un metodo para producir proteina tensioactiva alveolar
ES2072850T3 (es) Proteina recombinante surfactante alveolar.
DE68929045D1 (de) Verfahren zur herstellung und auswahl von peptiden mit spezifischen eigenschaften
ATE298800T1 (de) Verfahren und desoxyribonukleinsäure zur herstellung von gewebefaktor-protein
DK601786A (da) Hidtil ukendte prokoagulationsproteiner
FI104255B1 (fi) Menetelmä ihmisen seerumialbumiinin N-terminaalifragmentteja sisältävien fuusioproteiinien valmistamiseksi
ES550943A0 (es) Un procedimiento para preparar una proteina de fusion derivada de la secuencia de aminoacidos de la preprorrelaxina humana.
DK110190D0 (da) Alveolaere surfaktantproteiner
ES536027A0 (es) Un procedimiento para la produccion de un polipeptido
ATE175417T1 (de) Leadersequenz zur induzierung einer posttranslationalen modifikation von polypeptiden in bakterien, sowie dafür kodierendes gen
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
DE3777845D1 (de) Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie.
DE60129528D1 (de) Impfstoffe, die hybride Polypeptide mit mindestens zwei verschiedene Allergenen enthalten
PT90739A (pt) Processo para a preparacao de uma proteina dotada de actividade de inibicao de trombina
JPS6455181A (en) Artificial protein having particular amino acid composition and method for preparation thereof
DK0540560T3 (da) Ancrod-lignende proteiner, fremstilling og anvendelse deraf
DK694287A (da) Overfladeaktivt rekombinant-alveolaerprotein
IL91609A0 (en) Allelic variants of plasmodium falciparum merozoite surface antigen
IT8821667A0 (it) Procedimento per la preparazione di interleuchina 1 beta umana ricombinante in forma omogenea.
DE3485883D1 (de) Rekombinante materialien und verfahren zur herstellung von menschliche konnektive gewebe aktivierende peptide iii und deren analoge.
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.

Legal Events

Date Code Title Description
PC1A Transfer granted
FD1A Patent lapsed

Effective date: 20061202